# NEUROD1

## Overview
NEUROD1 is a gene that encodes the neuronal differentiation 1 protein, a basic helix-loop-helix (bHLH) transcription factor crucial for neurogenesis and pancreatic beta-cell development. The NEUROD1 protein plays a pivotal role in the differentiation of precursor cells into neurons, particularly in the cerebral cortex, and is essential for the survival of various neuronal populations, including those in the cerebellum and midbrain (Tutukova2021The). In the pancreas, NEUROD1 is vital for the development of insulin-producing beta cells, influencing the differentiation of endocrine cells (Mastracci2013Regulation). The protein's function is mediated through its ability to form heterodimers with other bHLH proteins, such as E47, enhancing its DNA binding specificity and transcriptional regulation capabilities (Mehmood2009Synergistic). Mutations in NEUROD1 are linked to metabolic and neurological disorders, including permanent neonatal diabetes mellitus and maturity-onset diabetes of the young type 6 (Brodosi2021NEUROD1; RubioCabezas2010Homozygous). Additionally, altered NEUROD1 expression is associated with certain neuroendocrine tumors, highlighting its significance in both developmental and pathological contexts (Osborne2013NeuroD1a).

## Structure
NEUROD1 is a basic helix-loop-helix (bHLH) transcription factor involved in neurogenesis and pancreatic beta-cell development. The primary structure of NEUROD1 consists of a sequence of amino acids that form the protein, which includes a DNA-binding domain crucial for its function (Longo2007Crystal). The secondary structure is characterized by alpha helices, particularly within the bHLH domain, which facilitates DNA binding and dimerization (Longo2007Crystal).

The tertiary structure of NEUROD1 involves the three-dimensional folding of the protein, allowing it to form a stable structure necessary for its interaction with DNA. The quaternary structure is defined by its ability to form heterodimers with other bHLH proteins, such as E47. This dimerization is essential for its function in regulating gene expression (Longo2007Crystal).

NEUROD1 undergoes post-translational modifications, such as phosphorylation, which can influence its activity and stability. The protein may also exist in different isoforms due to alternative splicing, which can result in variations in its function (Longo2007Crystal). The structural dynamics of NEUROD1, including its interactions with DNA and other proteins, are critical for its role in cellular differentiation processes (Longo2007Crystal).

## Function
NEUROD1 is a transcription factor that plays a crucial role in neuronal differentiation and function in healthy human cells. It is involved in the transition of precursor cells into differentiated neurons, particularly pyramidal neurons in the cerebral cortex. NEUROD1 is part of a sequence of transcription factors, including Pax6, Neurog2, Tbr2, and Tbr1, that guide this differentiation process (Tutukova2021The). In the brain, NEUROD1 is essential for the differentiation and survival of various neuronal populations, including granule cells in the cerebellum and dopaminergic neurons in the midbrain (Tutukova2021The).

NEUROD1 also plays a significant role in the development of the posterior nervous system, such as the cerebellum, brainstem, and spinal cord. It regulates the specification of inhibitory interneurons in the hindbrain and spinal cord, working alongside other Neurod family members like Neurod2 and Neurod6 (Tutukova2021The). In the pancreas, NEUROD1 is critical for the formation of insulin-producing beta cells and other hormone-expressing cell types. It interacts with the transcription factor Nkx2.2 to regulate the differentiation of endocrine cells, influencing whether progenitor cells become alpha or beta cells (Mastracci2013Regulation).

## Clinical Significance
Mutations in the NEUROD1 gene are associated with several diseases, primarily affecting metabolic and neurological systems. Homozygous mutations in NEUROD1 can lead to a syndrome characterized by permanent neonatal diabetes mellitus (PNDM) and neurological abnormalities, including developmental delay, cerebellar hypoplasia, profound sensorineural deafness, and visual impairment. These mutations result in frameshifts and premature truncation of the NEUROD1 protein, leading to a loss of its transactivation domain, which is crucial for its interaction with coactivators and regulation of target genes (RubioCabezas2010Homozygous).

NEUROD1 mutations are also linked to maturity-onset diabetes of the young type 6 (MODY6), a form of monogenic diabetes. This condition typically presents in young, non-obese patients with a family history of diabetes and no insulin resistance. In rare cases, homozygous mutations can cause neonatal diabetes (Brodosi2021NEUROD1; Zhang2020The).

Altered expression of NEUROD1 is implicated in neuroendocrine tumors, including aggressive cancers such as small cell lung cancer and melanoma. NEUROD1 contributes to tumor cell survival and metastasis by regulating the tyrosine kinase receptor TrkB (Osborne2013NeuroD1a). In pediatric neuroblastoma, increased NEUROD1 expression is associated with adverse clinical outcomes and shorter disease-free survival (Metovic2022Overexpression).

## Interactions
NEUROD1 interacts with several proteins and nucleic acids, playing a crucial role in transcriptional regulation. It forms heterodimers with the transcription factor E47, a class I basic helix-loop-helix (bHLH) factor, which is essential for its nuclear import and DNA binding specificity. This interaction enhances the nuclear import of NEUROD1, although the reverse is not true, indicating a specific role for E47 in facilitating NEUROD1's nuclear localization (Mehmood2009Synergistic). The E47-NEUROD1 heterodimer is stable and shows a higher DNA binding affinity compared to E47 homodimers, with specific hydrogen bonds and hydrophobic interactions contributing to its stability (Longo2007Crystal).

NEUROD1 also interacts with the transcription factor Sp1 to regulate the secretin gene. This interaction is independent of DNA presence and involves the C-terminal region of Sp1 and the bHLH domain of NEUROD1. The presence of NEUROD1 stabilizes Sp1's binding to the secretin promoter, forming a ternary complex that enhances transcriptional activation (Ray2007The). These interactions highlight NEUROD1's role in coordinating gene expression through complex protein-protein and protein-DNA interactions.


## References


[1. (Zhang2020The) Juan Zhang, Yanyan Jiang, Li Li, Yanpeng Wang, Ming Lu, Yating Chen, Mingqiang Song, Xiaoxu Ge, Ming Li, Ying Wang, Feng Wang, Miao Yu, Meisheng Jiang, Yanjun Liu, and Limei Liu. The first e59q mutation identified in the neurod1 gene in a chinese family with maturity-onset diabetes of the young: an observational study. Journal of Bio-X Research, 03(03):109–115, September 2020. URL: http://dx.doi.org/10.1097/JBR.0000000000000065, doi:10.1097/jbr.0000000000000065. This article has 2 citations.](https://doi.org/10.1097/JBR.0000000000000065)

[2. (RubioCabezas2010Homozygous) Oscar Rubio-Cabezas, Jayne A.L. Minton, Iren Kantor, Denise Williams, Sian Ellard, and Andrew T. Hattersley. Homozygous mutations inneurod1are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities. Diabetes, 59(9):2326–2331, June 2010. URL: http://dx.doi.org/10.2337/db10-0011, doi:10.2337/db10-0011. This article has 128 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.2337/db10-0011)

[3. (Mastracci2013Regulation) Teresa L. Mastracci, Keith R. Anderson, James B. Papizan, and Lori Sussel. Regulation of neurod1 contributes to the lineage potential of neurogenin3+ endocrine precursor cells in the pancreas. PLoS Genetics, 9(2):e1003278, February 2013. URL: http://dx.doi.org/10.1371/journal.pgen.1003278, doi:10.1371/journal.pgen.1003278. This article has 60 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1003278)

[4. (Longo2007Crystal) Antonella Longo, Gerald P. Guanga, and Robert B. Rose. Crystal structure of e47−neurod1/beta2 bhlh domain−dna complex: heterodimer selectivity and dna recognition,. Biochemistry, 47(1):218–229, December 2007. URL: http://dx.doi.org/10.1021/bi701527r, doi:10.1021/bi701527r. This article has 81 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi701527r)

[5. (Mehmood2009Synergistic) Rashid Mehmood, Noriko Yasuhara, Souichi Oe, Masahiro Nagai, and Yoshihiro Yoneda. Synergistic nuclear import of neurod1 and its partner transcription factor, e47, via heterodimerization. Experimental Cell Research, 315(10):1639–1652, June 2009. URL: http://dx.doi.org/10.1016/j.yexcr.2009.02.025, doi:10.1016/j.yexcr.2009.02.025. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.yexcr.2009.02.025)

[6. (Brodosi2021NEUROD1) Lucia Brodosi, Bianca Baracco, Vilma Mantovani, and Loris Pironi. Neurod1 mutation in an italian patient with maturity onset diabetes of the young 6: a case report. BMC Endocrine Disorders, October 2021. URL: http://dx.doi.org/10.1186/s12902-021-00864-w, doi:10.1186/s12902-021-00864-w. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12902-021-00864-w)

[7. (Tutukova2021The) Svetlana Tutukova, Victor Tarabykin, and Luis R. Hernandez-Miranda. The role of neurod genes in brain development, function, and disease. Frontiers in Molecular Neuroscience, June 2021. URL: http://dx.doi.org/10.3389/fnmol.2021.662774, doi:10.3389/fnmol.2021.662774. This article has 85 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2021.662774)

[8. (Metovic2022Overexpression) Jasna Metovic, Francesca Napoli, Simona Osella-Abate, Luca Bertero, Cristian Tampieri, Giulia Orlando, Maurizio Bianchi, Diana Carli, Franca Fagioli, Marco Volante, and Mauro Papotti. Overexpression of insm1, notch1, neurod1, and yap1 genes is associated with adverse clinical outcome in pediatric neuroblastoma. Virchows Archiv, 481(6):925–933, September 2022. URL: http://dx.doi.org/10.1007/s00428-022-03406-4, doi:10.1007/s00428-022-03406-4. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00428-022-03406-4)

[9. (Ray2007The) Subir K. Ray and Andrew B. Leiter. The basic helix-loop-helix transcription factor neurod1 facilitates interaction of sp1 with the secretin gene enhancer. Molecular and Cellular Biology, 27(22):7839–7847, November 2007. URL: http://dx.doi.org/10.1128/mcb.00438-07, doi:10.1128/mcb.00438-07. This article has 25 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.00438-07)

[10. (Osborne2013NeuroD1a) J K Osborne, J E Larsen, J X Gonzales, D S Shames, M Sato, I I Wistuba, L Girard, J D Minna, and M H Cobb. Neurod1 regulation of migration accompanies the differential sensitivity of neuroendocrine carcinomas to trkb inhibition. Oncogenesis, 2(8):e63–e63, August 2013. URL: http://dx.doi.org/10.1038/oncsis.2013.24, doi:10.1038/oncsis.2013.24. This article has 19 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/oncsis.2013.24)